RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

Show other versions (1)

<p><strong>Aim.</strong> To evaluate risk of repeated atherothrombotic events in patients survived acute coronary syndrome (ACS) and having poorly reduced platelet aggregation (proven by optical aggregometry) in response to acetylsalicylic acid (ASA) therapy.</p><p><...

Full description

Bibliographic Details
Main Authors: N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
острый коронарный синдром
антиагреганты
эффективность терапии
сердечно-сосудистые осложнения
Online Access:http://www.rpcardio.ru/jour/article/view/734

Internet

http://www.rpcardio.ru/jour/article/view/734

Similar Items